Inactive Instrument
InterCure Ltd. Share Price TEL AVIV STOCK EXCHANGE
Stocks
INCR
IL0011063760
Healthcare Facilities & Services
| Market Cap | 143M 418M 123M 113M 106M 199M 13.66B 202M 1.34B 523M 6.58B 536M 524M 22.83B | P/E Ratio 2024 |
-4.01x | P/E Ratio 2025 | -4.87x |
|---|---|---|---|---|---|
| Enterprise Value | 279M 818M 241M 222M 208M 390M 26.71B 396M 2.63B 1.02B 12.88B 1.05B 1.02B 44.65B | EV / Sales 2024 |
1.69x | EV / Sales 2025 | 1.16x |
| Free-Float |
73.95% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 23/12/2019 | |
Amos Cohen
DFI | Director of Finance/CFO | 47 | 29/02/2020 |
Itai Kabiljo
LAW | General Counsel | - | 31/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 50 | 02/09/2015 | |
David Salton
BRD | Director/Board Member | 66 | 13/12/2014 |
| Chairman | 55 | 12/02/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | -0.51% | - | - | 47.47M | |
| +2.70% | +2.70% | -22.45% | -32.14% | 150M | |
| -1.81% | -0.61% | +40.52% | +63.00% | 118M | |
| -5.45% | -1.89% | +70.49% | -25.71% | 112M | |
| -0.01% | +5.86% | +65.07% | +5.81% | 98.89M | |
| Average | -0.87% | +2.71% | +38.41% | +2.74% | 119.47M | |
| Weighted average by Cap. | -0.78% | +2.39% | +32.89% | +0.65% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 239M 701M 206M 190M 178M 333M 22.87B 339M 2.25B 876M 11.02B 897M 877M 38.22B | 270M 793M 233M 215M 201M 377M 25.87B 383M 2.55B 991M 12.47B 1.01B 992M 43.24B |
| Net income | -67.8M -199M -58.57M -53.88M -50.54M -94.66M -6.49B -96.2M -639M -249M -3.13B -254M -249M -10.85B | -35.71M -105M -30.85M -28.38M -26.62M -49.86M -3.42B -50.67M -337M -131M -1.65B -134M -131M -5.71B |
| Net Debt | 133M 389M 115M 106M 98.96M 185M 12.71B 188M 1.25B 487M 6.13B 498M 488M 21.25B | 136M 400M 118M 108M 102M 190M 13.05B 193M 1.29B 500M 6.29B 512M 501M 21.82B |
Employees
-
